StockData
Biofrontera Inc. logo

Biofrontera Inc. (BFRIW) stock

BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)

Close on Oct 30, 2026Market cap $12.96MP/E –Yield –

Biofrontera shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Biofrontera's shares outstanding was 13M at Jun 30, 2026. For fiscal 2025 it was 10M, up 84.4% from the year before. The highest annual figure on record is 440M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202510M+84.4%
FY2024Dec 31, 20246M+256.7%
FY2023Dec 31, 20232M+46.3%
FY2022Dec 31, 20221M-99.8%
FY2021Dec 31, 2021440M+38338.7%
FY2020Dec 31, 20201M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202613M+38.2%
Q1 FY2026Mar 31, 202612M+31.7%
Q4 FY2025Dec 31, 202512M+54.2%
Q3 FY2025Sep 30, 202511M+86.6%
Q2 FY2025Jun 30, 20259M+83.7%
Q1 FY2025Mar 31, 20259M+144.9%
Q4 FY2024Dec 31, 20248M+252.5%
Q3 FY2024Sep 30, 20246M+322.4%
Q2 FY2024Jun 30, 20245M+274.2%
Q1 FY2024Mar 31, 20244M+171.4%
Q4 FY2023Dec 31, 20232M+66.7%
Q3 FY2023Sep 30, 20231M+20.3%
Q2 FY2023Jun 30, 20231M+44.6%
Q1 FY2023Mar 31, 20231M+55.8%
Q4 FY2022Dec 31, 20221M+129.2%
Q3 FY2022Sep 30, 20221M+184.1%
Q2 FY2022Jun 30, 20221M+135.3%
Q1 FY2022Mar 31, 20221M+114.2%
Q4 FY2021Dec 31, 20211M+1123196.0%
Q3 FY2021Sep 30, 20210M–
Q2 FY2021Jun 30, 20210M–
Q1 FY2021Mar 31, 20210M–
Q3 FY2020Sep 30, 20200M–

More Biofrontera figures